We are pleased to announce the publication of our first annual review, Ysios Capital 2025 / H1 2026 Review, capturing a defining period for the firm.

Over the past eighteen months, we have combined strong portfolio execution with the expansion of our investment platform, turning years of scientific conviction and disciplined development into strategic transactions, clinical and commercial milestones, and new verticals.

Dive into the full 2025 / H1 2026 Review and explore the milestones shaping this new phase for Ysios Capital.

Ysios Capital 2025 / H1 2026 Review